Literature DB >> 15781620

Lack of correlation between p53-dependent transcriptional activity and the ability to induce apoptosis among 179 mutant p53s.

Yuichi Kakudo1, Hiroyuki Shibata, Kazunori Otsuka, Shunsuke Kato, Chikashi Ishioka.   

Abstract

Tumor suppressor p53-dependent apoptosis is thought to be one of the most important tumor-suppressive functions in human tumorigenesis. However, whether the major mechanism underlying the p53-dependent apoptosis is transactivation dependent or independent remains unclear. Using 179 mutant p53s with diverse transcriptional activities for distinct p53-binding sequences in yeast, we evaluated both their sequence-specific transcriptional activities on six p53 target genes and their ability to induce apoptosis in Saos-2 cells. These mutant p53s also represented diversity in their ability to both transactivate target genes and induce apoptosis. We identified 17 mutant p53s with superior ability to induce apoptosis than wild-type p53 that tend to cluster at residues 121 or 290 to 292. There was no significant correlation between the two functional properties on any single target gene examined. Furthermore, the 17 mutant p53s were not classified in a specific cluster by hierarchical cluster analysis on their diverse transcriptional activities, indicating that these mutant p53s were not similar in the transcriptional activity of downstream genes. These results suggested that transactivation-dependent apoptosis does not always play a major role in p53-dependent apoptosis, indirectly supporting the importance role of the transactivation-independent mechanism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15781620     DOI: 10.1158/0008-5472.CAN-04-2935

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  36 in total

Review 1.  p53 and regulation of bioactive sphingolipids.

Authors:  Linda A Heffernan-Stroud; Lina M Obeid
Journal:  Adv Enzyme Regul       Date:  2010-10-28

Review 2.  Towards an understanding of the role of p53 in adrenocortical carcinogenesis.

Authors:  Jonathan D Wasserman; Gerard P Zambetti; David Malkin
Journal:  Mol Cell Endocrinol       Date:  2011-09-10       Impact factor: 4.102

3.  Evolutionary Action Score of TP53 Identifies High-Risk Mutations Associated with Decreased Survival and Increased Distant Metastases in Head and Neck Cancer.

Authors:  David M Neskey; Abdullah A Osman; Thomas J Ow; Panagiotis Katsonis; Thomas McDonald; Stephanie C Hicks; Teng-Kuei Hsu; Curtis R Pickering; Alexandra Ward; Ameeta Patel; John S Yordy; Heath D Skinner; Uma Giri; Daisuke Sano; Michael D Story; Beth M Beadle; Adel K El-Naggar; Merrill S Kies; William N William; Carlos Caulin; Mitchell Frederick; Marek Kimmel; Jeffrey N Myers; Olivier Lichtarge
Journal:  Cancer Res       Date:  2015-01-29       Impact factor: 12.701

Review 4.  Beyond effector caspase inhibition: Bcl2L12 neutralizes p53 signaling in glioblastoma.

Authors:  Alexander H Stegh; Ronald A DePinho
Journal:  Cell Cycle       Date:  2011-01-01       Impact factor: 4.534

5.  MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy.

Authors:  Kensuke Kojima; Marina Konopleva; Ismael J Samudio; Masato Shikami; Maria Cabreira-Hansen; Teresa McQueen; Vivian Ruvolo; Twee Tsao; Zhihong Zeng; Lyubomir T Vassilev; Michael Andreeff
Journal:  Blood       Date:  2005-07-12       Impact factor: 22.113

6.  The biological impact of the human master regulator p53 can be altered by mutations that change the spectrum and expression of its target genes.

Authors:  Daniel Menendez; Alberto Inga; Michael A Resnick
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

7.  p53 Small-molecule inhibitor enhances temozolomide cytotoxic activity against intracranial glioblastoma xenografts.

Authors:  Eduard B Dinca; Kan V Lu; Jann N Sarkaria; Russell O Pieper; Michael D Prados; Daphne A Haas-Kogan; Scott R Vandenberg; Mitchel S Berger; C David James
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

Review 8.  Cytoplasmic functions of the tumour suppressor p53.

Authors:  Douglas R Green; Guido Kroemer
Journal:  Nature       Date:  2009-04-30       Impact factor: 49.962

9.  Transgelin induces apoptosis of human prostate LNCaP cells through its interaction with p53.

Authors:  Zhe-Wei Zhang; Zhi-Ming Yang; Yi-Chun Zheng; Zhao-Dian Chen
Journal:  Asian J Androl       Date:  2010-01-25       Impact factor: 3.285

10.  Regulation of p53 expression, phosphorylation and subcellular localization by a G-protein-coupled receptor.

Authors:  L Solyakov; E Sayan; J Riley; A Pointon; A B Tobin
Journal:  Oncogene       Date:  2009-08-03       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.